Ardelyx (ARDX) Operating Income (2013 - 2026)
Ardelyx (ARDX) reported Operating Income of -$32.8 million for Q1 2026, up 9.78% on a YoY basis from -$29.9 million in Q1 2025, and down 743.13% quarter-over-quarter from $5.1 million in Q4 2025.
Ardelyx (ARDX) Operating Income (2013 - 2026) Analysis & Trends
Ardelyx has reported Operating Income for 14 years, with the latest figure at -$32.8 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income rose 9.78% year-over-year to -$32.8 million; the trailing twelve-month figure through Mar 2026 stood at -$37.4 million (up 5.55% YoY), and the FY2025 full-year result was -$41.0 million, down 46.61% from the prior year.
- Operating Income for Q1 2026 stood at -$32.8 million, down from $5.1 million in the prior quarter.
- The five-year high for Operating Income was $12.1 million in Q4 2022, with the low at -$36.3 million in Q1 2025.
- Historically, Operating Income has averaged -$13.5 million across 5 years, with a median of -$16.6 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Income surged 134.43% — and 2023, when it slumped 330.47%.
- Ardelyx's Operating Income stood at $12.1 million in 2022, then tumbled by 330.47% to -$28.0 million in 2023, then soared by 129.03% to $8.1 million in 2024, then tumbled by 37.24% to $5.1 million in 2025, then slumped by 743.13% to -$32.8 million in 2026.
- The last three Operating Income figures came in at -$32.8 million (Q1 2026), $5.1 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | -32.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.79 Mn |
| Dec 31, 2025 | 5.10 Mn |
| Sep 30, 2025 | 4.67 Mn |
| Jun 30, 2025 | -14.40 Mn |
| Mar 31, 2025 | -36.35 Mn |
| Dec 31, 2024 | 8.13 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | -13.63 Mn |
| Mar 31, 2024 | -24.68 Mn |
| Dec 31, 2023 | -27.99 Mn |
| Sep 30, 2023 | 7.40 Mn |
| Jun 30, 2023 | -16.62 Mn |
| Mar 31, 2023 | -26.06 Mn |
| Dec 31, 2022 | 12.14 Mn |
| Sep 30, 2022 | -21.88 Mn |
| Jun 30, 2022 | -26.22 Mn |
| Mar 31, 2022 | -27.81 Mn |
| Dec 31, 2021 | -35.27 Mn |
| Sep 30, 2021 | -42.24 Mn |
| Jun 30, 2021 | -44.83 Mn |